Jan Komtebedde
Directeur Technique/Scientifique/R&D chez Corvia Medical, Inc.
Profil
Jan Komtebedde is currently the Chief Medical Officer & Senior Vice President at Corvia Medical, Inc. He previously worked as the Director-Structural Heart Business Unit at Abbott Laboratories, Director-Clinical Research & Development at Heartport, Inc., Chief Medical Officer & Executive Vice President at Ancora Heart, Inc., Vice President-Marketing & Business Development at Evalve, Inc., and as a Faculty Member at UC Davis School of Medicine.
He holds a doctorate degree from the University of Utrecht.
Postes actifs de Jan Komtebedde
| Sociétés | Poste | Début |
|---|---|---|
Corvia Medical, Inc.
 Corvia Medical, Inc. Medical SpecialtiesHealth Technology Corvia Medical, Inc. develops medical devices for the treatment of heart failure. It also offers transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction. The company was founded by David S. Celermajer and is headquartered in Tewksbury, MA. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Jan Komtebedde
| Sociétés | Poste | Fin |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Ancora Heart, Inc.
 Ancora Heart, Inc. Investment ManagersFinance Ancora Heart, Inc. manufactures medical devices for the treatment of mitral valve regurgitation. It develops percutaneous cardiac procedures for mitral valve regurgitation. The company was founded in 2001 by Lewis C. Pell, Niel F. Starksen and Nathan B. Pliam and is headquartered in Santa Clara, CA. | Directeur Technique/Scientifique/R&D | - |
Heartport, Inc.
 Heartport, Inc. Medical SpecialtiesHealth Technology Heartport, Inc. develops systems and procedures for heart surgery. The company's technologies allow surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. Heartport was founded in 1991 and is headquartered in Redwood City, CA. | Directeur Technique/Scientifique/R&D | - |
| UC Davis School of Medicine | Corporate Officer/Principal | - |
Evalve, Inc.
 Evalve, Inc. Medical SpecialtiesHealth Technology Evalve, Inc. designs, develops, manufactures and markets devices. It developed a proprietary system which enables percutaneous repair of cardiac valves. The firm's products reduces the risks, trauma, and costs associated with current open, arrested heart surgical options. The company was founded on June 9, 1999 and is headquartered in Menlo Park, CA. | Sales & Marketing | - |
Formation de Jan Komtebedde
| University of Utrecht | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Entreprise privées | 4 |
|---|---|
Evalve, Inc.
Evalve, Inc. Medical SpecialtiesHealth Technology Evalve, Inc. designs, develops, manufactures and markets devices. It developed a proprietary system which enables percutaneous repair of cardiac valves. The firm's products reduces the risks, trauma, and costs associated with current open, arrested heart surgical options. The company was founded on June 9, 1999 and is headquartered in Menlo Park, CA. | Health Technology |
Heartport, Inc.
Heartport, Inc. Medical SpecialtiesHealth Technology Heartport, Inc. develops systems and procedures for heart surgery. The company's technologies allow surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. Heartport was founded in 1991 and is headquartered in Redwood City, CA. | Health Technology |
Corvia Medical, Inc.
Corvia Medical, Inc. Medical SpecialtiesHealth Technology Corvia Medical, Inc. develops medical devices for the treatment of heart failure. It also offers transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction. The company was founded by David S. Celermajer and is headquartered in Tewksbury, MA. | Health Technology |
Ancora Heart, Inc.
Ancora Heart, Inc. Investment ManagersFinance Ancora Heart, Inc. manufactures medical devices for the treatment of mitral valve regurgitation. It develops percutaneous cardiac procedures for mitral valve regurgitation. The company was founded in 2001 by Lewis C. Pell, Niel F. Starksen and Nathan B. Pliam and is headquartered in Santa Clara, CA. | Finance |